Holen Sie sich die Stockscreener-App
69.63
4.96%
3.29
Handel nachbörslich:
69.60
-0.03
-0.04%
Schlusskurs vom Vortag:
$66.34
Offen:
$67.08
24-Stunden-Volumen:
19.33M
Relative Volume:
1.62
Marktkapitalisierung:
$11.70B
Einnahmen:
$803.32M
Nettoeinkommen (Verlust:
$-709.10M
KGV:
-8.9266
EPS:
-7.8003
Netto-Cashflow:
$-212.68M
1W Leistung:
+25.39%
1M Leistung:
+22.42%
6M Leistung:
-16.86%
1J Leistung:
+63.26%
1-Tages-Spanne:
$67.06
$71.85
1-Wochen-Bereich:
$56.81
$71.85
52-Wochen-Spanne:
$31.36
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Cetera Investment Advisers Invests $1.32 Million in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead? - MarketBeat
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? - TradingView
Tempus AI Skyrockets 5.43%—Is This the Dawn of a New Biotech Bull Run? - AInvest
Tempus AI stock price target raised to $72 from $62 at TD Cowen - Investing.com
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move? - sharewise.com
Tempus AI, Inc. Stock (TEM) Opinions on Recent Earnings and 2025 Outlook - Quiver Quantitative
Caitong International Asset Management Co. Ltd Grows Stock Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Arrowpoint Investment Partners Singapore Pte. Ltd. Invests $311,000 in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Has $2.60 Million Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Tempus AI, Inc. (NASDAQ: TEM) Shareholder Notice: Deadline in Lawsuit on August 12, 2025 - openPR.com
Tempus AI, Inc. (NASDAQ:TEM) Q2 2025 Earnings Call Transcript - MSN
Tempus AI investors have until Aug. 12, 2025, to file lead plaintiff applications. - AInvest
Tempus AI (NASDAQ:TEM) Price Target Raised to $68.00 at Morgan Stanley - MarketBeat
Tempus AI Stock: Evaluating the Risks and Rewards of a Guidance Raise - AInvest
Tempus AI Stock: Is It A Buy Following Guidance Raise? - Seeking Alpha
Tempus AI, Inc. Class A (TEM) Receives a Hold from Stifel Nicolaus - The Globe and Mail
Tempus AI Reports Strong Q2 2025 Growth - MSN
Benjamin Edwards Inc. Has $2.08 Million Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm - MarketScreener
TEM Securities Lawsuit Filed Against Tempus AI, Inc. Contact the DJS Law Group to Discuss Your Rights - MarketScreener
Tempus AI (NASDAQ:TEM) Shares Up 3.1% on Earnings Beat - MarketBeat
Blair William & Co. IL Buys 25,495 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI Shares Fall 0.08% as $750M Volume Ranks 126th Amid Lawsuit Over Financial Misstatements and SoftBank Misrepresentation - AInvest
Tempus AI’s Big Bet On Data And AI In Healthcare - Finimize
Tempus AI (NASDAQ:TEM) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
Tempus AI: Buy or Sell TEM Stock At $65? - Forbes
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming DeadlinesTEM - PR Newswire
Does Tempus AI Stock Have More Room For Growth? - Trefis
Stifel maintains Hold rating on Tempus AI stock, price target at $65 - Investing.com Canada
Virtu Financial LLC Takes Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitTEM - The Malaysian Reserve
Tempus AI (NASDAQ:TEM) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Tempus Reports Second Quarter 2025 Results - MarketScreener
Tempus AI sued for securities law violations; class action lawsuit. - AInvest
Traders Purchase High Volume of Call Options on Tempus AI (NASDAQ:TEM) - MarketBeat
TEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Tempus AI investors sue for securities violations between August 2024 and May 2025. - AInvest
Tempus AI (TEM) Is Up 10.9% After Upbeat Revenue Outlook and FDA Clearance for AI Heart Tool - simplywall.st
Securities Fraud and Market Volatility in AI-Driven Biotech Firms: A Cautionary Tale of Tempus AI - AInvest
Tempus AI (TEM) Raises 2025 Earnings Guidance Amid US$500 Million Equity Offering - Yahoo Finance
Pomerantz LLP Files Class Action Suit Against Tempus AI, Inc. Over Securities Fraud - AInvest
Tempus AI Exceeds Q2 Estimates, Raises Full-Year Revenue Guidance to $1.26 Billion - AInvest
Tempus AI Surges 9% on Q2 Beat, Raises 2025 Guidance for Second Time - AInvest
Tempus AI Reports Strong Q2 2025 Financial Growth - The Globe and Mail
The Case for Investing in Resilient, AI-Driven Healthcare Innovators Like Tempus AI - AInvest
5,131 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Avantax Advisory Services Inc. - MarketBeat
Tempus AI Inc (TEM) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances - Investing.com Canada
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.56%
3.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):